The companies will combine efforts in medical and pharmaceutical technology including robotics and instrumentation as part of a long-term agreement. TU Lankide. Grifols (MCE: GRF, MCE: GRF.P, NASDAQ: GRFS), a global leader in the production of plasma-derived medicines, and Mondragon, a worldwide leader in work cooperation and one of Spain’s most relevant business groups, today announced an agreement to jointly develop healthcare sector-related...